Interview with John B. Wong, MD, USPSTF member and coauthor of USPSTF Recommendation: Screening for Hypertension in Adults

Related Content:

• Screening for Hypertension in Adults
• The 2021 USPSTF Recommendation on Blood Pressure Screening
• USPSTF Recommendation: Screening for Hypertension in Adults
• USPSTF Recommendation Statement on Hypertension Screening in Adults
• Hypertension Screening Recommendation and Racial/Ethnic Disparities in Blood Pressure Control
• USPSTF Recommendations for Screening for Hypertension in Adults
• Patient Information: Screening for Hypertension in Adults
• The Surgeon General's Call to Action to Control Hypertension
• Hypertension, Obesity, and COVID-19

Dual antiplatelet therapy, typically aspirin and an oral P2Y12 receptor inhibitor (clopidogrel, prasugrel, ticagrelor, cangrelor), reduces adverse events after acute coronary syndrome (ACS) but choice of agent and optimal duration may be patient-specific. Umair Khalid, MD, a cardiologist at the Baylor School of Medicine in Houston, discusses how to use these agents in management of ACS.

Related Article(s):

Oral Antiplatelet Therapy After Acute Coronary Syndrome

Interest in space travel has increased since SpaceX’s first commercial launch to the International Space Station (ISS) in May 2020 and with efforts to send humans to Mars. Serena Auñón-Chancellor, MD, MPH, a physician-astronaut who completed a 6-month mission to the ISS in 2018 and is associate professor of clinical medicine at LSU Health Sciences Center in Baton Rouge and associate program director for the Aerospace Medicine Residency Program at University of Texas Medical Branch (UTMB) in Galveston, discusses how the human body and mind adapt to life in space.

Related Content:

Space Travel and Human Health, Part 1

Do Apollo Astronaut Deaths Shine a Light on Deep Space Radiation and Cardiovascular Disease?

Association of Structural Changes in the Brain and Retina After Long-Duration Spaceflight

Interest in space travel has increased since SpaceX’s first commercial launch to the International Space Station in May 2020 and with efforts to send humans to Mars. Jim Bagian, MD, a physician-astronaut who logged 337 hours in space between 1989 and 1991, is director of the Center for Healthcare Engineering and Patient Safety at the University of Michigan and discusses the effects of space travel on the human body and physiologic readjustments on return to earth.

Related Content:

Do Apollo Astronaut Deaths Shine a Light on Deep Space Radiation and Cardiovascular Disease?

Shyam Prabhakaran, MD, chairman of neurology at the University of Chicago, discusses the diagnosis and evaluation of patients who present with transient ischemic attack (TIA) and stroke.

Related Article:

Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke